Literature DB >> 20977466

Elusive equilibrium: the challenge of interpreting receptor pharmacology using calcium assays.

Steven J Charlton1, Georges Vauquelin.   

Abstract

UNLABELLED: Calcium is a key intracellular signal that controls manifold cellular processes over a wide temporal range. The development of calcium-sensitive fluorescent dyes and proteins revolutionized our ability to visualize this important second messenger and its complex signalling characteristics. The subsequent advent of high throughput plate-based fluorescence readers has resulted in the calcium assay becoming the most widely utilized assay system for the characterization of novel receptor ligands. In this review we discuss common approaches to calcium assays, paying particular attention to the potential issues associated with interpretation of receptor pharmacology using this system. Topics covered include dye saturation and forced-coupling of receptors to the calcium pathway, but special consideration is given to the influence of non-equilibrium conditions in this rapid signalling system. Modelling the calcium transient in a kinetic mode allows the influence of ligand kinetics, receptor reserve and read time to be explored. This demonstrates that observed ligand pharmacology at very early time points can be quite different to that determined after longer incubations, even resulting in reversal of agonist potency orders that may be misinterpreted as agonist biased signalling. It also shows that estimates of antagonist affinity, whether by Schild analysis or inhibition curves, are similarly affected by hemi-equilibrium conditions. Finally we end with a discussion on practical approaches to accurately estimate the affinity of insurmountable antagonists using calcium assays. LINKED ARTICLES: This article is part of a themed section on Analytical Receptor Pharmacology in Drug Discovery. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2010.161.issue-6.
© 2010 The Authors. British Journal of Pharmacology © 2010 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20977466      PMCID: PMC3000651          DOI: 10.1111/j.1476-5381.2010.00863.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  55 in total

Review 1.  Calcium sparks in smooth muscle.

Authors:  J H Jaggar; V A Porter; W J Lederer; M T Nelson
Journal:  Am J Physiol Cell Physiol       Date:  2000-02       Impact factor: 4.249

2.  Agonist-directed trafficking of porcine alpha(2A)-adrenergic receptor signaling in Chinese hamster ovary cells: l-isoproterenol selectively activates G(s).

Authors:  C B Brink; S M Wade; R R Neubig
Journal:  J Pharmacol Exp Ther       Date:  2000-08       Impact factor: 4.030

Review 3.  Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors.

Authors:  Emmanuel Hermans
Journal:  Pharmacol Ther       Date:  2003-07       Impact factor: 12.310

Review 4.  Calcium signalling: dynamics, homeostasis and remodelling.

Authors:  Michael J Berridge; Martin D Bootman; H Llewelyn Roderick
Journal:  Nat Rev Mol Cell Biol       Date:  2003-07       Impact factor: 94.444

5.  The assessment of antagonist potency under conditions of transient response kinetics.

Authors:  A Christopoulos; A M Parsons; M J Lew; E E El-Fakahany
Journal:  Eur J Pharmacol       Date:  1999-10-15       Impact factor: 4.432

6.  Exploring the mechanism of agonist efficacy: a relationship between efficacy and agonist dissociation rate at the muscarinic M3 receptor.

Authors:  David A Sykes; Mark R Dowling; Steven J Charlton
Journal:  Mol Pharmacol       Date:  2009-06-04       Impact factor: 4.436

Review 7.  From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function.

Authors:  Paul L Greer; Michael E Greenberg
Journal:  Neuron       Date:  2008-09-25       Impact factor: 17.173

8.  Chemical and physiological characterization of fluo-4 Ca(2+)-indicator dyes.

Authors:  K R Gee; K A Brown; W N Chen; J Bishop-Stewart; D Gray; I Johnson
Journal:  Cell Calcium       Date:  2000-02       Impact factor: 6.817

Review 9.  Chemical calcium indicators.

Authors:  R Madelaine Paredes; Julie C Etzler; Lora Talley Watts; Wei Zheng; James D Lechleiter
Journal:  Methods       Date:  2008-10-16       Impact factor: 3.608

10.  Miniaturization of intracellular calcium functional assays to 1536-well plate format using a fluorometric imaging plate reader.

Authors:  Peter Hodder; Rebecca Mull; Jason Cassaday; Kurtis Berry; Berta Strulovici
Journal:  J Biomol Screen       Date:  2004-08
View more
  39 in total

1.  BJP issue on drug discovery.

Authors:  Steven J Charlton; Richard A Bond
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

2.  Simplified models for heterobivalent ligand binding: when are they applicable and which are the factors that affect their target residence time.

Authors:  Georges Vauquelin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-28       Impact factor: 3.000

3.  Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567.

Authors:  Anindya Bhattacharya; Qi Wang; Hong Ao; James R Shoblock; Brian Lord; Leah Aluisio; Ian Fraser; Diane Nepomuceno; Robert A Neff; Natalie Welty; Timothy W Lovenberg; Pascal Bonaventure; Alan D Wickenden; Michael A Letavic
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

4.  Pharmacological characterization of tachykinin tetrabranched derivatives.

Authors:  Chiara Ruzza; Anna Rizzi; Davide Malfacini; Maria Camilla Cerlesi; Federica Ferrari; Erika Marzola; Caterina Ambrosio; Cristina Gro; Salvadori Severo; Tommaso Costa; Girolamo Calo; Remo Guerrini
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

5.  Luciferase Complementation Approaches to Measure GPCR Signaling Kinetics and Bias.

Authors:  Nicola C Dijon; Desislava N Nesheva; Nicholas D Holliday
Journal:  Methods Mol Biol       Date:  2021

6.  4-Aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-ones as N-formyl peptide receptor 1 (FPR1) antagonists.

Authors:  Liliya N Kirpotina; Igor A Schepetkin; Andrei I Khlebnikov; Olga I Ruban; Yunjun Ge; Richard D Ye; Douglas J Kominsky; Mark T Quinn
Journal:  Biochem Pharmacol       Date:  2017-07-08       Impact factor: 5.858

7.  Ligand-selective activation of heterologously-expressed mammalian olfactory receptor.

Authors:  K Ukhanov; Y Bobkov; E A Corey; B W Ache
Journal:  Cell Calcium       Date:  2014-08-04       Impact factor: 6.817

Review 8.  Allosteric modulation and functional selectivity of G protein-coupled receptors.

Authors:  Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Drug Discov Today Technol       Date:  2013

9.  Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt1]N/OFQ(1-13).

Authors:  Maria Camilla Cerlesi; Huiping Ding; Mark F Bird; Norikazu Kiguchi; Federica Ferrari; Davide Malfacini; Anna Rizzi; Chiara Ruzza; David G Lambert; Mei-Chuan Ko; Girolamo Calo; Remo Guerrini
Journal:  Eur J Pharmacol       Date:  2016-11-19       Impact factor: 4.432

10.  A kinetic view of GPCR allostery and biased agonism.

Authors:  J Robert Lane; Lauren T May; Robert G Parton; Patrick M Sexton; Arthur Christopoulos
Journal:  Nat Chem Biol       Date:  2017-08-18       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.